PL-017 TFA|CAS 0|DC Chemicals

Cas No.:
Chemical Name:	PL-017 TFA
Synonyms:	YP-{N(Me)Phe}-P-NH2
Formula:	C₃₁H₃₈F₃N₅O₇
M.Wt:	649.66
Sotrage:	Please store the product under the recommended conditions in the Certificate of Analysis.

Cat. No.	Product name	Field of application
DC47541	SC13	SC13 is a novel mitragynine analog with low-efficacy Mu opioid receptor agonism that displays antinociception with attenuated adverse effects.
DC47074	Sunobinop	Sunobinop (S 117957) is a modulator of the opioid receptor-like orphan receptor (ORL1).
DC46495	DIPPA hydrochloride	DIPPA (hydrochloride) is an irreversible, long-lasting, selective and high affinity κ-opioid receptor antagonist. DIPPA (hydrochloride) can be used for the research of anxiety and antidepressant.
DC45826	BMS-986121	BMS-986121 is a positive allosteric modulator (PAM) of the μ opioid receptor extracted from patent WO2014107344. BMS-986121 is built on a chemical scaffold representing a new chemotype for μ receptor PAMs.
DC45572	Nociceptin (1-13), amide TFA	Nociceptin (1-13), amide TFA is a potent ORL1 receptor (opioid receptor-like 1 receptor, OP4) agonist with a pEC50 of 7.9 for mouse vas deferens and a Ki of 0.75 nM for binding to rat forebrain membranes.
DC45524	Deltorphin 2 TFA	Deltorphin 2 TFA is a selective peptide agonist for the δ opioid receptor.
DC44749	6'-GNTI dihydrochloride	6'-GNTI dihydrochloride, a κ-opioid receptor (KOR) agonist, displays bias toward the activation of G protein-mediated signaling over β-arrestin2 recruitment. 6'-GNTI 6'-GNTI dihydrochloride only activates the Akt pathway in striatal neurons.
DC44147	UFP-101 TFA	UFP-101 TFA is a potent, selective, and competitive antagonist of the NOP receptor, with a pKi of 10.24. UFP-101 TFA displays >3000-fold selectivity over δ, μ and κ opioid receptors. UFP-101 TFA shows antidepressant-like effect.
DC42315	Cebranopadol ((1α,4α)stereoisomer)	Cebranopadol ((1α,4α)stereoisomer) is a stereoisomer of cebranopadol. Cebranopadol is a potent agonist activity on ORL-1.
DC41867	Dynorphin A (1-8)	Dynorphin A (1-8) is the predominant opioid peptide identified in placental tissue extracts. Dynorphin A (1-8) is the most likely natural ligand of the kappa receptor. The binding of 3H-Bremazocine to the purified kappa receptor is inhibited by Dynorphin A (1-8) (IC50=303 nM).